New SARS-CoV-2 vaccine paper

Draper group scientists have been working hard on the new Oxford - AstraZeneca  COVID vaccine. In this latest Nature Medicine article Jordan Barrett explores the antibody response to single and booster doses of the ChAdOx1 nCoV-19 vaccine. 

See the full report here:

Barrett, Jordan R., et al. "Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses." Nature medicine (2020): 1-10.